Sicart Associates LLC Increases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sicart Associates LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,303 shares of the exchange traded fund’s stock after acquiring an additional 200 shares during the period. Sicart Associates LLC’s holdings in SPDR S&P Biotech ETF were worth $524,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in XBI. Brookstone Capital Management purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at $284,000. Wealthcare Advisory Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at $257,000. Hennion & Walsh Asset Management Inc. raised its stake in SPDR S&P Biotech ETF by 86.4% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 4,390 shares of the exchange traded fund’s stock valued at $417,000 after buying an additional 2,035 shares during the last quarter. State of Michigan Retirement System bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $4,744,000. Finally, Evolution Wealth Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 4.3% during the 1st quarter. Evolution Wealth Advisors LLC now owns 29,484 shares of the exchange traded fund’s stock valued at $2,798,000 after acquiring an additional 1,203 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock traded down $0.46 during mid-day trading on Tuesday, reaching $98.03. 3,359,351 shares of the company’s stock traded hands, compared to its average volume of 9,362,177. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm has a 50 day moving average price of $99.10 and a two-hundred day moving average price of $94.70. The firm has a market capitalization of $7.47 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.